A modest ability of IL-4 to augment macrophage superoxide generation as compared to IL-13 is unlikely to have a major physiological impact that would explain opposing roles in cardiovascular disease such as atherosclerosis, hypertension, or MI. This evidence concerns the gene IL13 and hypertensive disorder.